XENE vs MSA

Comparison between Xenon Pharmaceuticals Inc (XENE, Company) and MSA Safety Inc (MSA, Company).

XENE is from the Healthcare sector, while MSA is from the Industrials sector.

5-Year PerformanceXENE has outperformed MSA, delivering a return of +29.9% compared to +2.7%

XENE vs MSA - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	XENE(COMPANY)	MSA(COMPANY)
Market Cap	$6.54B	$6.55B
Max Drawdown	90.43%	71.48%
Sharpe Ratio	1.44	0.08
5Y Beta	0.92	0.79
Industry	Biotechnology	Security & Protection Services
P/E Ratio	-14.55	22.67
Forward P/E	N/A	19.61
PEG Ratio	-0.36	9.84
Dividend Yield	N/A	1.26%
5Y Dividends CAGR	N/A	4.25%
5Y EPS CAGR	40.27%	20.02%
Debt to Equity	0.00%	45.24%
Free Cash Flow Yield	-4.70%	4.73%
P/S Ratio	727.44	3.40
P/B Ratio	4.89	4.79

Market Cap

XENE

$6.54B

Winner

MSA

$6.55B

Max Drawdown

XENE

90.43%

Winner

MSA

71.48%

Sharpe Ratio

Winner

XENE

1.44

MSA

0.08

5Y Beta

XENE

0.92

Winner

MSA

0.79

Industry

XENE

Biotechnology

MSA

Security & Protection Services

P/E Ratio

Winner

XENE

-14.55

MSA

22.67

Forward P/E

XENE

N/A

MSA

19.61

PEG Ratio

Winner

XENE

-0.36

MSA

9.84

Dividend Yield

XENE

N/A

MSA

1.26%

5Y Dividends CAGR

XENE

N/A

MSA

4.25%

5Y EPS CAGR

Winner

XENE

40.27%

MSA

20.02%

Debt to Equity

Winner

XENE

0.00%

MSA

45.24%

Free Cash Flow Yield

XENE

-4.70%

Winner

MSA

4.73%

P/S Ratio

XENE

727.44

Winner

MSA

3.40

P/B Ratio

XENE

4.89

Winner

MSA

4.79

XENE vs MSA - Historical Returns

Returns include dividend reinvestment.

Period	XENE	MSA
1 month	+28.83%	+6.68%
3 months	+14.63%	+5.31%
6 months	+67.53%	-5.55%
1 year	+111.83%	+2.27%
5 years(CAGR)	+29.95%	+2.70%
10 years(CAGR)	+24.13%	+13.29%
Max(CAGR)	+17.17%	+15.49%

Winner

XENE

+28.83%

MSA

+6.68%

Winner

XENE

+14.63%

MSA

+5.31%

Winner

XENE

+67.53%

MSA

-5.55%

Winner

XENE

+111.83%

MSA

+2.27%

5Y(CAGR)

Winner

XENE

+29.95%

MSA

+2.70%

10Y(CAGR)

Winner

XENE

+24.13%

MSA

+13.29%

Max(CAGR)

Winner

XENE

+17.17%

MSA

+15.49%

XENE vs MSA - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	XENE	MSA
2026	+50.55%	+7.49%
2025	+11.58%	-1.68%
2024	-12.71%	-0.19%
2023	+23.62%	+19.28%
2022	+24.82%	-1.31%
2021	+111.94%	+4.45%
2020	+12.10%	+17.61%
2019	+96.26%	+34.89%
2018	+119.48%	+21.47%
2017	-64.01%	+13.96%
2016	-3.27%	+66.79%
2015	-57.01%	-15.40%
2014	+88.10%	+7.28%
2013	N/A	+20.56%
2012	N/A	+31.32%
2011	N/A	+7.35%
2010	N/A	+19.69%
2009	N/A	+14.11%
2008	N/A	-51.53%
2007	N/A	+41.36%
2006	N/A	+0.89%
2005	N/A	-26.70%
2004	N/A	+90.76%
2003	N/A	+160.78%
2002	N/A	-18.11%
2001	N/A	+67.71%
2000	N/A	+20.00%
1999	N/A	+5.15%

XENE vs MSA Drawdown Comparison

The maximum drawdown for XENE was -90.43%, occurring on Nov 14, 2017. Recovery took 1696 trading sessions.

The maximum drawdown for MSA was -70.36%, occurring on Mar 9, 2009. Recovery took 1296 trading sessions.

The current XENE drawdown is -5.61%. The current MSA drawdown is -14.13%.

Rank	XENE	MSA
#1	-90.43% Jan 8, 2015 - Oct 4, 2021	-70.36% Dec 20, 2007 - Feb 14, 2013
#2	-43.59% Feb 9, 2024 - Mar 9, 2026	-45.18% Oct 4, 2001 - Aug 20, 2003
#3	-34.08% May 9, 2023 - Dec 22, 2023	-38.39% Feb 13, 2020 - Oct 8, 2020
#4	-30.14% Nov 5, 2021 - Aug 4, 2022	-35.28% Feb 22, 2021 - Jun 27, 2023
#5	-25.87% Nov 11, 2014 - Dec 11, 2014	-34.76% Jul 3, 2014 - Aug 23, 2016
#6	-18.40% Mar 9, 2026 - Jul 7, 2026	-34.27% Jul 16, 2024 - Feb 11, 2026
#7	-17.08% Mar 1, 2023 - May 3, 2023	-33.06% Dec 17, 2004 - Aug 8, 2007
#8	-16.98% Aug 24, 2022 - Feb 13, 2023	-26.47% Jun 13, 2000 - Dec 19, 2000
#9	-11.44% Oct 15, 2021 - Nov 2, 2021	-26.07% Jan 20, 2004 - Apr 5, 2004
#10	-11.09% Dec 11, 2014 - Dec 29, 2014	-22.60% Feb 12, 2026 - Jun 10, 2026
#11	-9.36% Feb 13, 2023 - Mar 1, 2023	-21.83% Apr 5, 2004 - Jun 7, 2004
#12	-8.58% Jan 8, 2024 - Feb 8, 2024	-20.64% Jun 1, 2017 - Nov 28, 2017
#13	-8.27% Aug 10, 2022 - Aug 24, 2022	-20.02% Sep 1, 2023 - Feb 29, 2024
#14	-6.08% Dec 29, 2014 - Jan 7, 2015	-19.78% Nov 16, 2018 - May 2, 2019
#15	-5.61% Jul 9, 2026 - Jul 16, 2026	-19.65% Aug 8, 2007 - Dec 20, 2007